featured
2019 Top Stories in Cardiology: The REDUCE-IT USA Study
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22.
- Bhatt DL, Steg PG, Miller M, et al. Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT. J Am Coll Cardiol. 2019;73(22):2791-2802.
- Bhatt DL, Miller M, Brinton EA, et al. REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States. Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044440. [Epub ahead of print.]
Disclosure statements are available on the authors' profiles: